STUDY OF CORRELATION BETWEEN MARKERS OF COAGULATION AND CLINICAL SEVERITY IN COVID 19
- Conditions
- Coronavirus as the cause of diseases classified elsewhere,
- Registration Number
- CTRI/2020/12/029984
- Lead Sponsor
- Smt NHL Municipal Medical College
- Brief Summary
**Study Design:**
Cross sectional, prospective, observational study
**Study Duration:**
24 months after IRB/CTRI approval
**Hypothesis:**
- In patients with COVID-19, there is a progression from adaptive hemostasis to pathologically induced Disseminated Intravascular Coagulopathy (DIC) to multi organ failure.
- Hence, coagulation profile in Covid 19 disease could be a significant marker to predict the clinical severity of disease and hence the overall outcome of patients from the disease.
**Aims and Objectives:**
- Studying the coagulation markers and their progression in COVID-19 .
- Correlation of coagulation markers with the clinical severity of COVID-19
- Outcome of patients with elevated coagulation markers in terms of:
- In-hospital stay (Duration and Type of stay: ICU or Ward)
- Morbidity (PE, DVT,Stroke,etc)
- Mortality
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- All
- Target Recruitment
- 100
Inpatients in General Medicine with a established diagnosis of COVID 19 infection( Laboratory confirmed ) Patients with abnormal coagulation markers Patients of age >18 years.
- Patients with proven others causes of coagulopathy.
- VTE, DVT, Recent Surgery/Trauma, Pregnancy, Cancer Patients already on anticoagulant therapy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method In-hospital stay (Duration and Type of stay: ICU or Ward) At Baseline, Every 3rd Day till Discharge/Death
- Secondary Outcome Measures
Name Time Method Morbidity (PE, DVT,Stroke,etc) Mortality
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Sardar Vallabhbhai Patel Institute of Medical Science and Research (SVPIMSR)
🇮🇳Ahmadabad, GUJARAT, India
Sardar Vallabhbhai Patel Institute of Medical Science and Research (SVPIMSR)🇮🇳Ahmadabad, GUJARAT, IndiaDR AKASH J JANIPrincipal investigator8460706921akash.jani@gmail.com